Correspondence 0001013762-24-002643 from Inmune Bio, Inc. (INMB) (CIK 0001711754) (INMB)
Inmune Bio, Inc. (INMB) (CIK 0001711754)
Date: July 30, 2024 · CIK: 0001711754 · Accession: 0001013762-24-002643
AI Filing Summary & Sentiment
File numbers found in text: 333-279036
Letter
INmune Bio Inc.
225 NE Mizner Blvd., Suite 640
Boca Raton, Florida 33432
(858)-964-3720
July 30, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: INmune Bio Inc.
Registration Statement on Form S-3
File No. 333-279036
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on August 1, 2024, or as soon thereafter as practicable.
Please contact Christian Lichtenberger, Esq. of Sichenzia Ross Ference Carmel LLP at (646)-810-0591, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
Very truly yours,
INMUNE BIO INC.
Show Raw Text
CORRESP
1
filename1.htm
INmune Bio Inc.
225 NE Mizner Blvd., Suite 640
Boca Raton, Florida 33432
(858)-964-3720
July 30, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: INmune Bio Inc.
Registration Statement on Form S-3
File No. 333-279036
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated
under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement
referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on August 1, 2024, or as soon thereafter
as practicable.
Please contact Christian Lichtenberger,
Esq. of Sichenzia Ross Ference Carmel LLP at (646)-810-0591, as soon as the Registration Statement has been declared effective, or if
you have any other questions or concerns regarding this matter.
Very truly yours,
INMUNE BIO INC.
By:
/s/ David Moss
David Moss
Chief Financial Officer